Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature (Q43796622)

26 November 2017

Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature (English)

1 reference

26 November 2017

Guan Y

1

1 reference

26 November 2017

Zhang Y

2

1 reference

26 November 2017

Schneider A

3

1 reference

26 November 2017

Davis L

4

1 reference

26 November 2017

Breyer RM

5

1 reference

26 November 2017

Breyer MD

6

1 reference

26 November 2017

1 December 2001

1 reference

American Journal of Physiology - Renal Physiology

26 November 2017

1 reference

26 November 2017

281

1 reference

26 November 2017

F1036-46

1 reference

26 November 2017

6

1 reference

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

26 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

PPARgamma, the ultimate thrifty gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Lipid-binding proteins in rat and human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

PPAR gamma and the treatment of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Structural properties of the adipocyte lipid binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocyte-type fatty acid-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

The fatty acid transport function of fatty acid-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

Members of the fatty acid binding protein family are differentiation factors for the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.0025.2001

10.1152/AJPRENAL.0025.2001

21 January 2018

Identifiers

DOI

0 references

1 reference